AnandaniNellanMD

Pediatric Hematology & Oncology • Aurora, CO

Assistant Professor

Join to view full profile

Dr. Nellan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nellan's full profile

Already have an account?

Office
13123 E 16th Ave # B115
Aurora, CO 80045
Phone+1 720-777-6740

Fax+1 720-777-7226

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2013 - 2016
University of Virginia Medical CenterResidency, Pediatrics, 2010 - 2013
University of Arizona College of MedicineClass of 2010

Certifications & Licensure

MD State Medical License 2013 - 2025
CO State Medical License 2016 - 2021
VA State Medical License Active through 2013
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Targeted therapy done right: Direct sonic hedgehog inhibition for sonic hedgehog medulloblastoma.
Anandani Nellan, Sadhana Jackson
Neuro-Oncology. 2024-04-05
Investigation of white blood cell characteristics in cerebrospinal fluid samples at pediatric brain tumor diagnosis.
Hunter R Greer, Kristen Miller, Sadaf Samay, Anandani Nellan, Adam L Green
Journal of Neuro-Oncology. 2022-09-01
6 citations
Immunotherapy Associated Neurotoxicity in Pediatric Oncology.
Haneen Shalabi, Anandani Nellan, Nirali N Shah, Juliane Gust
Frontiers in Oncology. 2022-01-01

Journal Articles

Improved CNS Exposure to Tocilizumab After Cerebrospinal Fluid Compared to Intravenous Administration in Rhesus Macaques
Brigitte C Widemann, Daniel W Lee, Anandani Nellan, Blood

Press Mentions

For Childhood Eye Cancer, Researchers Investigating “Packaged” CAR T CellsNovember 10th, 2020

Grant Support

Effects of the immunosuppressive ependymoma (EPN) tumor microenvironment on anti-HER2 chimeric antigen receptor (CAR) T cellsNational Institutes of Health2018–2020